DD55034A - - Google Patents

Info

Publication number
DD55034A
DD55034A DD55034DA DD55034A DD 55034 A DD55034 A DD 55034A DD 55034D A DD55034D A DD 55034DA DD 55034 A DD55034 A DD 55034A
Authority
DD
German Democratic Republic
Application number
Publication of DD55034A publication Critical patent/DD55034A/xx

Links

DD55034D DD55034A (https=)

Publications (1)

Publication Number Publication Date
DD55034A true DD55034A (https=)

Family

ID=251385

Family Applications (1)

Application Number Title Priority Date Filing Date
DD55034D DD55034A (https=)

Country Status (1)

Country Link
DD (1) DD55034A (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096798A3 (fr) * 2003-04-25 2006-01-26 Sanofi Aventis Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096798A3 (fr) * 2003-04-25 2006-01-26 Sanofi Aventis Derives de 2-acylamino-4-phenylthiazole, leur preparation et leur application en therapeutique

Similar Documents

Publication Publication Date Title
US7777041B2 (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
US20060160869A1 (en) Ubiquitin ligase inhibitors
JP2006524669A5 (https=)
US20250051296A1 (en) Modulators of myocyte lipid accumulation and insulin resistance and methods of use thereof
WO2020142865A1 (zh) 一种苯甲酰胺类化合物、中间体、制备方法及应用
DD55034A (https=)
BE704312A (https=)